A protocol for modelled evaluations to maximise the long-term health and economic gains of lung cancer interventions in Australia: The Lung cancer Evaluation And Policy program (LEAPp)

Background: Tobacco control interventions in Australia have had success in recent decades, international screening trials have yielded significant mortality benefits, and therapeutic innovation in disease management is burgeoning; however, lung cancer remains the leading cause of cancer death and disease burden in Australia and the most appropriate combination of interventions to address this is unclear. Underpinned by modelling infrastructure, The Daffodil Centre’s Lung cancer Evaluation And Policy program (LEAPp) combines large-scale linked data analysis, clinical trial data, statistical projections, evidence review, and stakeholder engagement to quantify and optimise the long-term health and economic impacts of lung cancer interventions for Australia, both alone and in combination.